Conmed

Conmed FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Conmed (CNMD) as of Sep 27, 2026 is 320.65 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 116.21 % — a change of 175.93% (higher).

FCF Conversion

320.65 %

YoY

175.93%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Conmed is 2026 320.65 % . FCF Conversion Rate (FCF/EBITDA) of Conmed was 2025 116.21 % . It decreases by 175.93% higher compared to the previous year.

The Conmed FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
142.44 USD
Jan 1, 2019
262.29 USD
Jan 1, 2020
541.33 USD
Jan 1, 2021
154.94 USD
Jan 1, 2022
-14.37 USD
Jan 1, 2023
164.94 USD
Jan 1, 2024
116.21 USD
Jan 1, 2025
320.65 USD
The Conmed FCF Conversion history
YEARFCF ConversionYoY
320.65 %+175.93%
116.21 %-29.54%
164.94 %-1,247.74%
-14.37 %-109.27%
154.94 %-71.38%
541.33 %+106.39%
262.29 %+84.13%
142.44 %+49.91%
95.02 %-40.63%
160.05 %+47.65%
108.40 %-29.88%
154.59 %—
Access this data via the Eulerpool API

Conmed Stock analysis

What does Conmed do? Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community. Conmed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Conmed stock

FCF Conversion Rate (FCF/EBITDA) of Conmed is 320.65 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Conmed changed from 116.21 % to 320.65 %, representing a 175.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Conmed since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Conmed with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Conmed

All Key Metrics — Conmed